NDLI: Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy

Content Provider	PubMed Central
Author	Anchel, González-barriga Julia, Kranzen Croes, Huib J. E. Bijl, Suzanne Broek, Walther J. A. A. Van Den Kessel, Ingeborg D. G. Van Engelen, Baziel G. M. Van Deutekom, Judith C. T. Van Wieringa, Bé Mulders, Susan A. M. Wansink, Derick G.
Editor	Artero, Ruben
Copyright Year	2015
Abstract	Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG•CAG)n repeat. Promising strategies for treatment of DM1 patients are currently being tested. These include antisense oligonucleotides and drugs for elimination of expanded RNA or prevention of aberrant binding to RNP proteins. A significant hurdle for preclinical development along these lines is efficient systemic delivery of compounds across endothelial and target cell membranes. It has been reported that DM1 patients show elevated levels of markers of muscle damage or loss of sarcolemmal integrity in their serum and that splicing of dystrophin, an essential protein for muscle membrane structure, is abnormal. Therefore, we studied cell membrane integrity in DM1 mouse models commonly used for preclinical testing. We found that membranes in skeletal muscle, heart and brain were impermeable to Evans Blue Dye. Creatine kinase levels in serum were similar to those in wild type mice and expression of dystrophin protein was unaffected. Also in patient muscle biopsies cell surface expression of dystrophin was normal and calcium-positive fibers, indicating elevated intracellular calcium levels, were only rarely seen. Combined, our findings indicate that cells in DM1 tissues do not display compromised membrane integrity. Hence, the cell membrane is a barrier that must be overcome in future work towards effective drug delivery in DM1 therapy.
Related Links	http://dx.doi.org/10.1371/journal.pone.0121556
Starting Page	121556
File Format	PDF
ISSN	19326203
e-ISSN	19326203
Journal	PLoS ONE
Issue Number	3
Volume Number	10
Language	English
Publisher	Public Library of Science
Publisher Date	2015-03-01
Access Restriction	Open
Rights Holder	Public Library of Science
Subject Keyword	Biochemistry, Genetics and Molecular Biology(all) Agricultural and Biological Sciences(all) Medicine(all) Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2

Deregulated MicroRNAs in Myotonic Dystrophy Type 2

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1

Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1

RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2

Correction: Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy

Similar Documents

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2

Deregulated MicroRNAs in Myotonic Dystrophy Type 2

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1

Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1

RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2

Correction: Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy